Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

Overview | Financials
Company Name Verrica Pharmaceuticals Inc.
Symbol VRCA
Currency USD
Price 0.83
Market Cap 37,844,100
Dividend Yield 0%
52-week-range 0.704 - 11.41
Industry Biotechnology
Sector Healthcare
CEO Mr. Ted White
Website https://www.verrica.com

An error occurred while fetching data.

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is

Related Stocks

Movano Inc. logo

Movano Inc.

MOVE

4.35 USD

Lumos Pharma, Inc. logo

Lumos Pharma, Inc.

LUMO

4.359 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Curis, Inc. logo

Curis, Inc.

CRIS

4.42 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.85 USD

Mustang Bio, Inc. logo

Mustang Bio, Inc.

MBIO

0.255 USD

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.54 USD

Neuronetics, Inc. logo

Neuronetics, Inc.

STIM

1.17 USD

Financials

Numbers are in millions USD

Numbers are in millions USD